| Comprehensive molecular portraits of human breast tumours Brigham & Women’s Hospital & Harvard Medical School Chin Lynda 9 11 Park ... Nature 490 (7418), 61-70, 2012 | 11012 | 2012 |
| The cancer genome atlas pan-cancer analysis project JN Weinstein, EA Collisson, GB Mills, KR Shaw, BA Ozenberger, K Ellrott, ... Nature genetics 45 (10), 1113-1120, 2013 | 6398 | 2013 |
| Multiplatform analysis of 12 cancer types reveals molecular classification within and across tissues of origin KA Hoadley, C Yau, DM Wolf, AD Cherniack, D Tamborero, S Ng, ... Cell 158 (4), 929-944, 2014 | 1522 | 2014 |
| PARPi triggers the STING-dependent immune response and enhances the therapeutic efficacy of immune checkpoint blockade independent of BRCAness J Shen, W Zhao, Z Ju, L Wang, Y Peng, M Labrie, TA Yap, GB Mills, ... Cancer research 79 (2), 311-319, 2019 | 467 | 2019 |
| ARID1A deficiency promotes mutability and potentiates therapeutic antitumor immunity unleashed by immune checkpoint blockade J Shen, Z Ju, W Zhao, L Wang, Y Peng, Z Ge, ZD Nagel, J Zou, C Wang, ... Nature medicine 24 (5), 556-562, 2018 | 421 | 2018 |
| Comparison of RNA-Seq by poly (A) capture, ribosomal RNA depletion, and DNA microarray for expression profiling W Zhao, X He, KA Hoadley, JS Parker, DN Hayes, CM Perou BMC genomics 15, 1-11, 2014 | 347 | 2014 |
| Comparative oncogenomics identifies breast tumors enriched in functional tumor-initiating cells JI Herschkowitz, W Zhao, M Zhang, J Usary, G Murrow, D Edwards, ... Proceedings of the National Academy of Sciences 109 (8), 2778-2783, 2012 | 254 | 2012 |
| BRD4 inhibition is synthetic lethal with PARP inhibitors through the induction of homologous recombination deficiency C Sun, J Yin, Y Fang, J Chen, KJ Jeong, X Chen, CP Vellano, Z Ju, ... Cancer cell 33 (3), 401-416. e8, 2018 | 242 | 2018 |
| Characterization of human cancer cell lines by reverse-phase protein arrays J Li, W Zhao, R Akbani, W Liu, Z Ju, S Ling, CP Vellano, P Roebuck, Q Yu, ... Cancer cell 31 (2), 225-239, 2017 | 207 | 2017 |
| Breast cancer quantitative proteome and proteogenomic landscape HJ Johansson, F Socciarelli, NM Vacanti, MH Haugen, Y Zhu, I Siavelis, ... Nature communications 10 (1), 1600, 2019 | 170 | 2019 |
| Lunatic fringe deficiency cooperates with the Met/Caveolin gene amplicon to induce basal-like breast cancer K Xu, J Usary, PC Kousis, A Prat, DY Wang, JR Adams, W Wang, AJ Loch, ... Cancer cell 21 (5), 626-641, 2012 | 136 | 2012 |
| Tumor evolution in two patients with basal-like breast cancer: a retrospective genomics study of multiple metastases KA Hoadley, MB Siegel, KL Kanchi, CA Miller, L Ding, W Zhao, X He, ... PLoS medicine 13 (12), e1002174, 2016 | 123 | 2016 |
| Integrative clustering reveals a novel split in the luminal A subtype of breast cancer with impact on outcome MR Aure, V Vitelli, S Jernström, S Kumar, M Krohn, EU Due, TH Haukaas, ... Breast Cancer Research 19, 1-18, 2017 | 102 | 2017 |
| Genomic and evolutionary classification of lung cancer in never smokers T Zhang, P Joubert, N Ansari-Pour, W Zhao, PH Hoang, R Lokanga, ... Nature genetics 53 (9), 1348-1359, 2021 | 98 | 2021 |
| Functional variomics and network perturbation: connecting genotype to phenotype in cancer S Yi, S Lin, Y Li, W Zhao, GB Mills, N Sahni Nature Reviews Genetics 18 (7), 395-410, 2017 | 98 | 2017 |
| Explore, visualize, and analyze functional cancer proteomic data using the cancer proteome atlas J Li, R Akbani, W Zhao, Y Lu, JN Weinstein, GB Mills, H Liang Cancer research 77 (21), e51-e54, 2017 | 97 | 2017 |
| Radiomics for lung adenocarcinoma manifesting as pure ground-glass nodules: invasive prediction Y Sun, C Li, L Jin, P Gao, W Zhao, W Ma, M Tan, W Wu, S Duan, Y Shan, ... European radiology 30, 3650-3659, 2020 | 95 | 2020 |
| Genetic and epigenetic intratumor heterogeneity impacts prognosis of lung adenocarcinoma X Hua, W Zhao, AC Pesatori, D Consonni, NE Caporaso, T Zhang, B Zhu, ... Nature communications 11 (1), 2459, 2020 | 89 | 2020 |
| Predicting drug responsiveness in human cancers using genetically engineered mice J Usary, W Zhao, D Darr, PJ Roberts, M Liu, L Balletta, O Karginova, ... Clinical Cancer Research 19 (17), 4889-4899, 2013 | 85 | 2013 |
| Inhibition of the ATM/Chk2 axis promotes cGAS/STING signaling in ARID1A-deficient tumors L Wang, L Yang, C Wang, W Zhao, Z Ju, W Zhang, J Shen, Y Peng, C An, ... The Journal of clinical investigation 130 (11), 5951-5966, 2020 | 79 | 2020 |
Gordon MillsOregon Health & Science UniversityVerified email at ohsu.edu
